JP2022548752A - 安定化細胞を含有体液サンプルのマルチモード解析 - Google Patents

安定化細胞を含有体液サンプルのマルチモード解析 Download PDF

Info

Publication number
JP2022548752A
JP2022548752A JP2022517916A JP2022517916A JP2022548752A JP 2022548752 A JP2022548752 A JP 2022548752A JP 2022517916 A JP2022517916 A JP 2022517916A JP 2022517916 A JP2022517916 A JP 2022517916A JP 2022548752 A JP2022548752 A JP 2022548752A
Authority
JP
Japan
Prior art keywords
cell
stabilized
blood
cells
fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022517916A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022548752A5 (cg-RX-API-DMAC7.html
Inventor
アンナ ババヤン
アンドレア ウリウス
ダニエル グレルツ
カル ギュンター
Original Assignee
キアゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by キアゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング filed Critical キアゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング
Publication of JP2022548752A publication Critical patent/JP2022548752A/ja
Publication of JP2022548752A5 publication Critical patent/JP2022548752A5/ja
Priority to JP2025178306A priority Critical patent/JP2026026080A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Physiology (AREA)
JP2022517916A 2019-09-24 2020-09-24 安定化細胞を含有体液サンプルのマルチモード解析 Pending JP2022548752A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025178306A JP2026026080A (ja) 2019-09-24 2025-10-23 安定化細胞を含有体液サンプルのマルチモード解析

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19199283.3 2019-09-24
EP19199283 2019-09-24
PCT/EP2020/076801 WO2021058692A1 (en) 2019-09-24 2020-09-24 Multimodal analysis of stabilized cell-containing bodily fluid samples

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025178306A Division JP2026026080A (ja) 2019-09-24 2025-10-23 安定化細胞を含有体液サンプルのマルチモード解析

Publications (2)

Publication Number Publication Date
JP2022548752A true JP2022548752A (ja) 2022-11-21
JP2022548752A5 JP2022548752A5 (cg-RX-API-DMAC7.html) 2023-10-02

Family

ID=68210700

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022517916A Pending JP2022548752A (ja) 2019-09-24 2020-09-24 安定化細胞を含有体液サンプルのマルチモード解析
JP2025178306A Pending JP2026026080A (ja) 2019-09-24 2025-10-23 安定化細胞を含有体液サンプルのマルチモード解析

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025178306A Pending JP2026026080A (ja) 2019-09-24 2025-10-23 安定化細胞を含有体液サンプルのマルチモード解析

Country Status (6)

Country Link
US (1) US20220349014A1 (cg-RX-API-DMAC7.html)
EP (1) EP4034653A1 (cg-RX-API-DMAC7.html)
JP (2) JP2022548752A (cg-RX-API-DMAC7.html)
CN (1) CN114450402A (cg-RX-API-DMAC7.html)
CA (1) CA3148731A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021058692A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023150760A2 (en) * 2022-02-04 2023-08-10 Cornell University Enrichment and characterization of rare circulating cells, including progenitor cells, from peripheral blood, and uses thereof
CN114700186B (zh) * 2022-03-17 2023-04-18 中国科学院海洋研究所 一种刺参体液样品外泌体分离的方法
WO2025122970A1 (en) * 2023-12-06 2025-06-12 National Resilience, Inc. Detecting contaminants during therapy development and manufacture
CN117866891A (zh) * 2024-01-15 2024-04-12 延边大学 一种富血小板血浆外泌体的提取方法
EP4741056A1 (en) * 2024-11-06 2026-05-13 Beckman Coulter, Inc. Method for processing a biological sample and device therefor

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2721085A1 (en) * 2008-04-09 2009-10-15 California Institute Of Technology Capture agents and related methods and systems for detecting and/or sorting targets
CN113388605A (zh) 2011-09-26 2021-09-14 凯杰有限公司 用于分离细胞外核酸的快速方法
AU2012314514B2 (en) 2011-09-26 2018-03-15 Qiagen Gmbh Stabilisation and isolation of extracellular nucleic acids
WO2013045458A1 (en) 2011-09-26 2013-04-04 Preanalytix Gmbh Stabilisation and isolation of extracellular nucleic acids
JP6608280B2 (ja) 2012-09-25 2019-11-20 キアゲン ゲーエムベーハー 生物学的試料の安定化
EP2976424B1 (en) * 2013-03-18 2018-10-03 Qiagen GmbH Stabilisation of biological samples
US20160281133A1 (en) 2013-03-18 2016-09-29 Qiagen Gmbh Stabilization and isolation of extracellular nucleic acids
CA2940692C (en) * 2014-03-18 2025-07-08 Qiagen Gmbh STABILIZATION AND ISOLATION OF EXTRACELLULAR NUCLEIC ACIDS
EP3885438A1 (en) 2015-06-10 2021-09-29 QIAGEN GmbH Method for isolating extracellular nucleic acids using anion exchange particles
SI3368683T1 (sl) * 2015-10-27 2020-07-31 Pharmassist Ltd Postopek za kvantifikacijo PD-L1
JP7166169B2 (ja) 2015-11-20 2022-11-07 キアゲン ゲーエムベーハー 細胞外核酸の滅菌のための滅菌組成物を調製する方法
CN106480017A (zh) * 2016-11-15 2017-03-08 武汉海吉力生物科技有限公司 同时提取循环肿瘤细胞dna和肿瘤游离dna的试剂盒
JP7293244B2 (ja) * 2017-10-19 2023-06-19 ストレック, インコーポレイテッド 溶血、凝固調節および細胞外小胞の安定化のための組成物
EP3905881A1 (en) * 2019-01-04 2021-11-10 QIAGEN GmbH Urine stabilization

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
日本ベクトン・ディッキンソン株式会社[ONLINE], JPN6024041346, 2017, ISSN: 0005622957 *

Also Published As

Publication number Publication date
CN114450402A (zh) 2022-05-06
US20220349014A1 (en) 2022-11-03
WO2021058692A1 (en) 2021-04-01
CA3148731A1 (en) 2021-04-01
JP2026026080A (ja) 2026-02-16
AU2020353273A1 (en) 2022-03-17
EP4034653A1 (en) 2022-08-03

Similar Documents

Publication Publication Date Title
JP2026026080A (ja) 安定化細胞を含有体液サンプルのマルチモード解析
JP6750178B2 (ja) 生物試料の安定化
JP6761850B2 (ja) 濾過を通して生物学的サンプルから抽出された又は単離された希少細胞の多重分析のための方法
JP6407248B2 (ja) 細胞外核酸の安定化および単離
Whiteside The potential of tumor-derived exosomes for noninvasive cancer monitoring
JP6664332B2 (ja) 細胞外核酸の安定化および単離
Zijlstra et al. Prostasomes as a source of diagnostic biomarkers for prostate cancer
JP2019013250A (ja) 生物学的試料の安定化
JP7548904B2 (ja) 尿安定化
US20150132738A1 (en) Method For Identification Of Non-Hematogeneous Karocytes Enriched From Body Fluid Of Humans Or Animals
WO2019214063A1 (zh) 一种循环肿瘤细胞的检测方法
CN105683753B (zh) 试剂用于裂解红细胞的用途以及涉及其的方法和试剂盒
Bünger et al. Diversity of assessing circulating tumor cells (CTCs) emphasizes need for standardization: a CTC Guide to design and report trials
KR102380529B1 (ko) 전이성 전립선 암의 진단 및 예후 예측을 위한 혈중종양세포 기반 바이오 마커 조성물
JP2016519286A (ja) 白血球の枯渇による循環腫瘍細胞の濃縮
JP2011160738A (ja) ヒト肝臓がん細胞HepG2に特異的な結合性を有するDNAアプタマー
JP2019136044A (ja) 細胞外核酸の安定化および単離
Stafim da Cunha et al. Endothelial Extracellular Vesicles as Biomarkers of Toxic Molecules
Tsamchoe Plasma-based extracellular vesicle proteomic signatures for non-invasive risk stratification and early response diagnosis of colorectal cancer liver metastases
HK1225798A1 (en) Use of a reagent for the lysis of erythrocytes as well as methods and kits relating thereto
HK1209186B (en) Process for making a diagnosis of invasive cancer

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230922

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230922

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241015

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250115

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250317

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250414

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250623